Avricore Healthの空売り状況は、投資家がAvricore Healthの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Avricore Health (OTC:AVCRF) 株価情報, 空売り情報

Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and the sale of testing panels.

AVRICORE HEALTH INC ORD by Avricore Health Inc.

Avricore Health Inc

Mizuho analyst Vijay Rakesh maintains Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) with a Outperform and lowers the price target from $180 to $160.

News

Price Target

Analyst Ratings

Mizuho Maintains Outperform on Advanced Micro Devices, Lowers Price Target to $160

HC Wainwright &amp; Co. analyst Arthur He reiterates Solid Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDB#NASDAQ">SLDB</a>) with a Buy and maintains $16 price target.

Reiteration

SLDB

HC Wainwright & Co. Reiterates Buy on Solid Biosciences, Maintains $16 Price Target

Rumors

Trading Ideas

BROS

Watching Dutch Bros; Shares See A Pop In Volume To The Upside, Traders Circulate Stock Picked By Investor Business Daily SwingTrader

Mizuho analyst Vijay Rakesh maintains Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) with a Outperform and lowers the price target from $220 to $210.

AMAT

Mizuho Maintains Outperform on Applied Mat, Lowers Price Target to $210

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates GH Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GHRS#NASDAQ">GHRS</a>) with a Buy and maintains $40 price target.

GHRS

HC Wainwright & Co. Reiterates Buy on GH Research, Maintains $40 Price Target

Mizuho analyst Vijay Rakesh maintains Credo Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) with a Outperform and raises the price target from $70 to $85.

CRDO

Mizuho Maintains Outperform on Credo Technology Group, Raises Price Target to $85

Needham analyst Gerald Pascarelli reiterates Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) with a Buy and maintains $280 price target.

Needham Reiterates Buy on Constellation Brands, Maintains $280 Price Target

Mizuho analyst Vijay Rakesh maintains Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) with a Outperform and raises the price target from $245 to $260.

AVGO

Mizuho Maintains Outperform on Broadcom, Raises Price Target to $260

Contracts

MPLN

MultiPlan and J2 Health Form Strategic Agreement To Enhance Network Services And Analytics

WIIM

Shares of California utility companies are trading lower amid wildfires in California.

Needham analyst Serge Belanger upgraded Collegium Pharmaceutical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLL#NASDAQ">COLL</a>) to Buy from Hold, <a target="_blank" href="https://www.benzinga.com/quote/COLL/analyst-ratings" rel="noreferrer noopener">with a price forecast of $46.</a>
Recently, Collegium provided 2025 guidance, expecting a top-line of $735 million &#8211; $750 million, including Jornay PM sales over $135 million and adjusted <a target="_blank" href="https://www.benzinga.com//node/42871470" rel="noreferrer noopener">EBITDA of $435 million &#8211; $450 million.</a>
The analyst highlights that the guidance was higher than their estimates and aligned with Street consensus.
Per the analyst, the company&#8217;s valuation doesn&#8217;t fully reflect its growth, profitability, and cash flow, boosted by Jornay PM&#8217;s expected contribution.
Belanger also highlighted that the company&#8217;s valuation presents an attractive entry point, and that the continued growth of its pain portfolio, especially Xtampza and Belbuca, remains underappreciated.
Also Read: <a target="_blank" href="https://www.benzinga.com/economics/macro-economic-events/25/01/42917321/consumer-inflation-worries-highest-since-2008-u-of-m-survey-says-wall-street-tumbles-to-2-month-lows" rel="noreferrer noopener">Consumer Inflation Worries Highest Since 2008, U Of M Survey Says: Wall Street Tumbles To 2-Month Lows</a>
Both drugs have intellectual property through the early-to-mid 2030s, and a recent settlement delays the launch of Nucynta generics until at least 2027, the analyst writes.
The analyst notes that Collegium is significantly undervalued compared to its peers based on key sales and EBITDA metrics from 2025 guidance. The company has historically traded at a discount due to concerns over the generic threat to its pain products and its focus on opioids, which has limited its M&amp;A potential.
However, the analyst views Collegium&#8217;s entry into neurology and its future CNS product portfolio as essential steps in diversifying away from opioid products, which could bring its valuation more in line with its peers.
Price Action: COLL shares are trading lower by 1.02% to $33.00 at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42912208/delta-stock-jumps-after-record-q4-earnings-and-strong-2025-outlook" target="_blank" rel="noreferrer noopener">Delta Takes Flight As Q4 Earnings Beat Expectations, Fueled By Premium Travel Demand And Efficiency Gains</a></li>
</ul>
Photo: Gorodenkoff/Shutterstock.com.

Analyst Color

Equities

Upgrades

Markets

Movers

General

COLL

Collegium's Revenue Outlook And CNS Expansion Signal Undervalued Opportunity, Says Needham

RBC Capital analyst Irene Nattel maintains Aritzia (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ATZ#TSX">ATZ</a>) with a Outperform and raises the price target from C$65 to C$73.

TSX:ATZ

RBC Capital Maintains Outperform on Aritzia, Raises Price Target to C$73

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Morgan Stanley analyst Matthew Harrison upgraded the rating for Gilead Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) from Equal-Weight to Overweight and raised the price target from $87 to $113. Gilead Sciences shares closed at $89.14 on Wednesday. <a href="https://www.benzinga.com/quote/GILD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Jon Tower upgraded McDonald&#8217;s Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) from Neutral to Buy and boosted the price target from $311 to $334. McDonald&#8217;s shares closed at $286.90 on Wednesday. <a href="https://www.benzinga.com/quote/MCD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Needham analyst Tom Nikic upgraded the rating for Lululemon Athletica Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) from Hold to Buy and announced a $475 price target. Lululemon shares closed at $392.92 on Wednesday. <a href="https://www.benzinga.com/quote/LULU/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Jay Sole upgraded Burlington Stores, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) from Neutral to Buy and raised the price target from $280 to $360. Burlington Stores shares closed at $285.95 on Wednesday. <a href="https://www.benzinga.com/quote/BURL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Piper Sandler analyst Anna Andreeva upgraded the rating for NIKE, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) from Neutral to Overweight and raised the price target from $72 to $90. Nike shares closed at $71.29 on Wednesday. <a href="https://www.benzinga.com/quote/NKE/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying Nike stock? Here&#8217;s what analysts think:
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="549" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10123444/image-59-1024x549.png" alt="" class="wp-image-728650" style="width:588px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10123444/image-59-1024x549.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10123444/image-59-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10123444/image-59-768x412.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10123444/image-59.png 1132w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42917071/top-2-health-care-stocks-that-are-ticking-portfolio-bombs-2">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

BURL

GILD

LULU

This McDonald's Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Piper Sandler analyst David Amsellem maintains Avadel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) with a Overweight and lowers the price target from $24 to $13.

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

Piper Sandler Maintains Overweight on Avadel Pharmaceuticals, Lowers Price Target to $13

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BKSY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$10.00</td>
<td>$55.0K</td>
<td>1.9K</td>
<td>1.0K</td>
</tr>
<tr>
<td>UAL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$107.00</td>
<td>$80.1K</td>
<td>169</td>
<td>506</td>
</tr>
<tr>
<td>CPA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$110.00</td>
<td>$42.9K</td>
<td>30</td>
<td>369</td>
</tr>
<tr>
<td>GEV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$290.00</td>
<td>$69.2K</td>
<td>1.9K</td>
<td>114</td>
</tr>
<tr>
<td>CAT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$390.00</td>
<td>$27.3K</td>
<td>496</td>
<td>67</td>
</tr>
<tr>
<td>DE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$410.00</td>
<td>$111.6K</td>
<td>364</td>
<td>61</td>
</tr>
<tr>
<td>BA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$175.00</td>
<td>$41.6K</td>
<td>1.0K</td>
<td>60</td>
</tr>
<tr>
<td>PH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/21/25</td>
<td>$660.00</td>
<td>$82.8K</td>
<td>119</td>
<td>36</td>
</tr>
<tr>
<td>FDX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$330.00</td>
<td>$31.6K</td>
<td>325</td>
<td>25</td>
</tr>
<tr>
<td>UBER</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$40.00</td>
<td>$46.6K</td>
<td>158</td>
<td>15</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For BKSY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKSY#NYSE">BKSY</a>), we notice a call option trade that happens to be bullish, expiring in 7 day(s) on January 17, 2025. This event was a transfer of 1000 contract(s) at a $10.00 strike. The total cost received by the writing party (or parties) was $55.0K, with a price of $55.0 per contract. There were 1962 open contracts at this strike prior to today, and today 1046 contract(s) were bought and sold. 
• Regarding UAL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>), we observe a put option sweep with bearish sentiment. It expires in 7 day(s) on January 17, 2025. Parties traded 391 contract(s) at a $107.00 strike. This particular put needed to be split into 13 different trades to become filled. The total cost received by the writing party (or parties) was $80.1K, with a price of $205.0 per contract. There were 169 open contracts at this strike prior to today, and today 506 contract(s) were bought and sold. 
• For CPA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPA#NYSE">CPA</a>), we notice a call option sweep that happens to be bearish, expiring in 126 day(s) on May 16, 2025. This event was a transfer of 369 contract(s) at a $110.00 strike. This particular call needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $42.9K, with a price of $116.0 per contract. There were 30 open contracts at this strike prior to today, and today 369 contract(s) were bought and sold. 
• For GEV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>), we notice a call option sweep that happens to be neutral, expiring in 7 day(s) on January 17, 2025. This event was a transfer of 10 contract(s) at a $290.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $69.2K, with a price of $6928.0 per contract. There were 1958 open contracts at this strike prior to today, and today 114 contract(s) were bought and sold. 
• For CAT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAT#NYSE">CAT</a>), we notice a call option sweep that happens to be neutral, expiring in 70 day(s) on March 21, 2025. This event was a transfer of 55 contract(s) at a $390.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $27.3K, with a price of $495.0 per contract. There were 496 open contracts at this strike prior to today, and today 67 contract(s) were bought and sold. 
• For DE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DE#NYSE">DE</a>), we notice a put option trade that happens to be bearish, expiring in 70 day(s) on March 21, 2025. This event was a transfer of 60 contract(s) at a $410.00 strike. The total cost received by the writing party (or parties) was $111.6K, with a price of $1860.0 per contract. There were 364 open contracts at this strike prior to today, and today 61 contract(s) were bought and sold. 
• Regarding BA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>), we observe a put option trade with bullish sentiment. It expires in 161 day(s) on June 20, 2025. Parties traded 25 contract(s) at a $175.00 strike. The total cost received by the writing party (or parties) was $41.6K, with a price of $1665.0 per contract. There were 1068 open contracts at this strike prior to today, and today 60 contract(s) were bought and sold. 
• Regarding PH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>), we observe a call option sweep with bullish sentiment. It expires in 315 day(s) on November 21, 2025. Parties traded 16 contract(s) at a $660.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $82.8K, with a price of $5177.0 per contract. There were 119 open contracts at this strike prior to today, and today 36 contract(s) were bought and sold. 
• For FDX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>), we notice a call option trade that happens to be bullish, expiring in 343 day(s) on December 19, 2025. This event was a transfer of 25 contract(s) at a $330.00 strike. The total cost received by the writing party (or parties) was $31.6K, with a price of $1265.0 per contract. There were 325 open contracts at this strike prior to today, and today 25 contract(s) were bought and sold. 
• For UBER (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>), we notice a call option trade that happens to be bearish, expiring in 524 day(s) on June 18, 2026. This event was a transfer of 15 contract(s) at a $40.00 strike. The total cost received by the writing party (or parties) was $46.6K, with a price of $3110.0 per contract. There were 158 open contracts at this strike prior to today, and today 15 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

BlackSky Technology Inc. Class A Common Stock

BKSY

UBER

10 Industrials Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Financials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>UPST</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$50.00</td>
<td>$25.7K</td>
<td>812</td>
<td align="right">664</td>
</tr>
<tr>
<td>JPM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$220.00</td>
<td>$30.8K</td>
<td>4.0K</td>
<td align="right">630</td>
</tr>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$300.00</td>
<td>$183.3K</td>
<td>9.5K</td>
<td align="right">476</td>
</tr>
<tr>
<td>BANC</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$10.00</td>
<td>$25.3K</td>
<td>4.2K</td>
<td align="right">350</td>
</tr>
<tr>
<td>MA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$370.00</td>
<td>$26.5K</td>
<td>2.5K</td>
<td align="right">336</td>
</tr>
<tr>
<td>SQ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$90.00</td>
<td>$53.2K</td>
<td>4.9K</td>
<td align="right">320</td>
</tr>
<tr>
<td>ROOT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$70.00</td>
<td>$26.0K</td>
<td>116</td>
<td align="right">304</td>
</tr>
<tr>
<td>DAVE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$75.00</td>
<td>$207.9K</td>
<td>1.7K</td>
<td align="right">233</td>
</tr>
<tr>
<td>V</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$315.00</td>
<td>$65.0K</td>
<td>888</td>
<td align="right">176</td>
</tr>
<tr>
<td>AXP</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/24/25</td>
<td>$280.00</td>
<td>$43.0K</td>
<td>289</td>
<td align="right">157</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding UPST (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>), we observe a put option sweep with bearish sentiment. It expires in 189 day(s) on July 18, 2025. Parties traded 26 contract(s) at a $50.00 strike. This particular put needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $25.7K, with a price of $990.0 per contract. There were 812 open contracts at this strike prior to today, and today 664 contract(s) were bought and sold. 
• Regarding JPM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), we observe a put option sweep with bearish sentiment. It expires in 161 day(s) on June 20, 2025. Parties traded 45 contract(s) at a $220.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $30.8K, with a price of $684.0 per contract. There were 4016 open contracts at this strike prior to today, and today 630 contract(s) were bought and sold. 
• Regarding COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we observe a call option trade with bearish sentiment. It expires in 42 day(s) on February 21, 2025. Parties traded 130 contract(s) at a $300.00 strike. The total cost received by the writing party (or parties) was $183.3K, with a price of $1410.0 per contract. There were 9586 open contracts at this strike prior to today, and today 476 contract(s) were bought and sold. 
• Regarding BANC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BANC#NYSE">BANC</a>), we observe a call option trade with neutral sentiment. It expires in 189 day(s) on July 18, 2025. Parties traded 50 contract(s) at a $10.00 strike. The total cost received by the writing party (or parties) was $25.3K, with a price of $507.0 per contract. There were 4200 open contracts at this strike prior to today, and today 350 contract(s) were bought and sold. 
• For MA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MA#NYSE">MA</a>), we notice a call option trade that happens to be bearish, expiring in 7 day(s) on January 17, 2025. This event was a transfer of 2 contract(s) at a $370.00 strike. The total cost received by the writing party (or parties) was $26.5K, with a price of $13275.0 per contract. There were 2572 open contracts at this strike prior to today, and today 336 contract(s) were bought and sold. 
• Regarding SQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQ#NYSE">SQ</a>), we observe a put option sweep with bullish sentiment. It expires in 7 day(s) on January 17, 2025. Parties traded 72 contract(s) at a $90.00 strike. This particular put needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $53.2K, with a price of $740.0 per contract. There were 4929 open contracts at this strike prior to today, and today 320 contract(s) were bought and sold. 
• For ROOT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>), we notice a put option sweep that happens to be bearish, expiring in 7 day(s) on January 17, 2025. This event was a transfer of 100 contract(s) at a $70.00 strike. This particular put needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $26.0K, with a price of $260.0 per contract. There were 116 open contracts at this strike prior to today, and today 304 contract(s) were bought and sold. 
• Regarding DAVE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>), we observe a call option sweep with bullish sentiment. It expires in 97 day(s) on April 17, 2025. Parties traded 99 contract(s) at a $75.00 strike. This particular call needed to be split into 13 different trades to become filled. The total cost received by the writing party (or parties) was $207.9K, with a price of $2100.0 per contract. There were 1711 open contracts at this strike prior to today, and today 233 contract(s) were bought and sold. 
• Regarding V (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), we observe a put option sweep with bearish sentiment. It expires in 42 day(s) on February 21, 2025. Parties traded 50 contract(s) at a $315.00 strike. This particular put needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $65.0K, with a price of $1300.0 per contract. There were 888 open contracts at this strike prior to today, and today 176 contract(s) were bought and sold. 
• For AXP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>), we notice a put option trade that happens to be neutral, expiring in 14 day(s) on January 24, 2025. This event was a transfer of 139 contract(s) at a $280.00 strike. The total cost received by the writing party (or parties) was $43.0K, with a price of $310.0 per contract. There were 289 open contracts at this strike prior to today, and today 157 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BANC

COIN

DAVE

ROOT

UPST

10 Financials Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$135.00</td>
<td>$28.6K</td>
<td>38.9K</td>
<td>27.8K</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/10/25</td>
<td>$32.00</td>
<td>$46.5K</td>
<td>819</td>
<td>5.5K</td>
</tr>
<tr>
<td>MSFT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$420.00</td>
<td>$31.5K</td>
<td>10.5K</td>
<td>4.8K</td>
</tr>
<tr>
<td>MU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/10/25</td>
<td>$99.00</td>
<td>$31.9K</td>
<td>2.6K</td>
<td>4.7K</td>
</tr>
<tr>
<td>PLTR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/10/25</td>
<td>$70.00</td>
<td>$50.2K</td>
<td>13.1K</td>
<td>4.6K</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/24/25</td>
<td>$235.00</td>
<td>$90.0K</td>
<td>1.8K</td>
<td>3.0K</td>
</tr>
<tr>
<td>MCHP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$57.50</td>
<td>$62.9K</td>
<td>351</td>
<td>1.8K</td>
</tr>
<tr>
<td>MSTR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/10/25</td>
<td>$335.00</td>
<td>$33.0K</td>
<td>1.8K</td>
<td>1.6K</td>
</tr>
<tr>
<td>MARA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$20.00</td>
<td>$79.0K</td>
<td>3.1K</td>
<td>1.3K</td>
</tr>
<tr>
<td>AVGO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$220.00</td>
<td>$130.0K</td>
<td>4.5K</td>
<td>853</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we notice a put option trade that happens to be neutral, expiring in 7 day(s) on January 17, 2025. This event was a transfer of 100 contract(s) at a $135.00 strike. The total cost received by the writing party (or parties) was $28.6K, with a price of $286.0 per contract. There were 38952 open contracts at this strike prior to today, and today 27880 contract(s) were bought and sold. 
• For IONQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>), we notice a call option trade that happens to be bullish, is expiring today. Parties traded 300 contract(s) at a $32.00 strike. The total cost received by the writing party (or parties) was $46.5K, with a price of $155.0 per contract. There were 819 open contracts at this strike prior to today, and today 5537 contract(s) were bought and sold. 
• For MSFT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), we notice a call option sweep that happens to be bearish, expiring in 7 day(s) on January 17, 2025. This event was a transfer of 70 contract(s) at a $420.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $31.5K, with a price of $451.0 per contract. There were 10538 open contracts at this strike prior to today, and today 4834 contract(s) were bought and sold. 
• For MU (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), we notice a put option sweep that happens to be bearish, is expiring today. Parties traded 370 contract(s) at a $99.00 strike. This particular put needed to be split into 82 different trades to become filled. The total cost received by the writing party (or parties) was $31.9K, with a price of $86.0 per contract. There were 2634 open contracts at this strike prior to today, and today 4757 contract(s) were bought and sold. 
• For PLTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), we notice a put option sweep that happens to be bullish, is expiring today. Parties traded 150 contract(s) at a $70.00 strike. This particular put needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $50.2K, with a price of $335.0 per contract. There were 13165 open contracts at this strike prior to today, and today 4686 contract(s) were bought and sold. 
• Regarding AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we observe a call option sweep with bearish sentiment. It expires in 14 day(s) on January 24, 2025. Parties traded 200 contract(s) at a $235.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $90.0K, with a price of $450.0 per contract. There were 1822 open contracts at this strike prior to today, and today 3073 contract(s) were bought and sold. 
• Regarding MCHP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>), we observe a call option sweep with bearish sentiment. It expires in 42 day(s) on February 21, 2025. Parties traded 262 contract(s) at a $57.50 strike. This particular call needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $62.9K, with a price of $240.0 per contract. There were 351 open contracts at this strike prior to today, and today 1833 contract(s) were bought and sold. 
• For MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we notice a put option sweep that happens to be bearish, is expiring today. Parties traded 50 contract(s) at a $335.00 strike. This particular put needed to be split into 9 different trades to become filled. The total cost received by the writing party (or parties) was $33.0K, with a price of $660.0 per contract. There were 1881 open contracts at this strike prior to today, and today 1637 contract(s) were bought and sold. 
• For MARA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>), we notice a call option sweep that happens to be bearish, expiring in 21 day(s) on January 31, 2025. This event was a transfer of 1000 contract(s) at a $20.00 strike. This particular call needed to be split into 7 different trades to become filled. The total cost received by the writing party (or parties) was $79.0K, with a price of $79.0 per contract. There were 3114 open contracts at this strike prior to today, and today 1300 contract(s) were bought and sold. 
• For AVGO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>), we notice a put option trade that happens to be bearish, expiring in 42 day(s) on February 21, 2025. This event was a transfer of 125 contract(s) at a $220.00 strike. The total cost received by the writing party (or parties) was $130.0K, with a price of $1040.0 per contract. There were 4570 open contracts at this strike prior to today, and today 853 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

IONQ

MARA

MCHP

MSFT

MSTR

NVDA

PLTR

10 Information Technology Stocks Whale Activity In Today's Session

Piper Sandler analyst Joseph Catanzaro maintains Halozyme Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HALO#NASDAQ">HALO</a>) with a Neutral and raises the price target from $52 to $53.

HALO

Piper Sandler Maintains Neutral on Halozyme Therapeutics, Raises Price Target to $53

NVIDIA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) has grown to being among the largest companies in the world due to its <a href="https://www.benzinga.com/tech/24/12/42547442/microsof-scoops-up-485000-nvidia-ai-chips-twice-as-many-as-its-closest-rival-meta-report">AI chip dominance</a>. One analyst sees the Santa Clara, California-based company&#8217;s lead expanding.
The Nvidia Analyst: In a note published Thursday, Bank of America analyst Vivek Arya reiterated a Buy rating for Nvidia with a price target of $190.
Main Takeaways: Arya&#8217;s semiconductor team hosted Nvidia CFO Colette Kress for an investor meeting in Las Vegas. 
Arya is more confident in Nvidia as an &#8220;AI incubator.&#8221;
&#8220;NVDA&#8217;s unique/highly leverageable silicon/system/software platform is spawning new growth engines in physical AI/robotics, onpremise AI workstations (Project Digits), AI PC, autonomous driving (Uber, Toyota partnership) &#8211; no other merchant or ASIC rival can match this,&#8221; the analyst said.
Arya noted other positive signs for the company&#8217;s flagship Blackwell chip.
&#8220;Overall, the tone for AI demand remains very strong across both Hopper and new Blackwell platforms,&#8221; the analyst said. &#8220;Hopper run rate is not necessarily tied to demand, but rather to the overall supply situation which can impact the product mix. NVDA noted Hopper remains a very capable product for many customers today, but most customers have outlined their desire for (supply-constrained) Blackwell which is now available across 15 partners and 200+ configurations.&#8221;
Arya foresees possible near-term volatility in Nvidia&#8217;s stock due to possible trade headwinds during the incoming Trump Administration.
Price Action: Shares of Nvidia were down 2.8% to $136.14 at the time of publication Friday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42913622/dollar-soars-to-27-month-highs-30-year-yields-hit-5-stocks-tumble-jobs-report-oil-spike-darken-feds-interest-rate-cut-hopes">Dollar Soars To 27-Month Highs, 30-Year Yields Hit 5%, Stocks Tumble As Jobs Report, Oil Spike Darken Fed&#8217;s Interest Rate Cut Hopes</a></li>
</ul>
Photo: Shutterstock

Government

Tech

Nvidia's Lead Expands, Analyst Says: 'AI Demand Remains Very Strong'

A new chapter in the ongoing saga of digital assets is about to unfold <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42686215/2025-crypto-policy-preview-warns-clarity-will-come-from-congress-not-the-sec">on Capitol Hill</a>.
What Happened: The <a href="https://www.foxbusiness.com/politics/senate-banking-committee-launch-subcommittee-digital-assets">announcement </a>that the Senate Banking Committee will create its first-ever subcommittee dedicated to cryptocurrency and blockchain technology signifies far more than just another committee meeting.
It represents a shift in the political landscape, signaling a broader acceptance and integration of digital currencies into the <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42701446/crypto-industry-anticipates-policy-overhaul-under-trump-administration">mainstream of U.S. governance</a>.
This isn&#8217;t merely a procedural move; it&#8217;s an acknowledgment of the cryptocurrency sector&#8217;s growing influence, both economically and politically. 
The formation of this subcommittee, under the leadership of Senator Tim Scott (R-SC), comes on the heels of a Republican sweep of the Senate, suggesting a concerted effort to align policy with the evolving world of finance.
It suggests a deliberate move toward addressing the complex issues surrounding digital assets, acknowledging their potential to disrupt the traditional financial system. 
While the motivations may differ from individual to individual, the message is clear, the United States is no longer ignoring this asset class.
The choice of Senator Cynthia Lummis (R-Wyo.), a known Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) advocate, to potentially chair this new subcommittee is a strong signal that the committee isn&#8217;t just a performative gesture but one that will actively explore the possibilities of digital assets.
This, combined with the involvement of other pro-crypto senators, suggests that the committee will not seek to stifle innovation, but rather to define a clear path for it. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42908193/exclusive-answering-key-questions-about-bitcoins-future-before-inauguration">EXCLUSIVE: Answering Key Questions About Bitcoin&#8217;s Future 10 Days Before The Inauguration</a>
Why It Matters: It&#8217;s a shift away from a primarily cautious approach to a potentially more proactive and innovation-focused one.
It is understood the goal of this committee is to work towards a cohesive legal framework for the industry, something that has been highly sought after by the industry.
With the GOP controlling both the House and Senate, and a President who has <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42827796/maga-meme-coin-surges-20-boosting-donald-trumps-crypto-portfolio-11-9m">expressed interest in the crypto industry</a>, this newly established subcommittee is poised to make substantial headway in shaping the country&#8217;s policy toward digital assets.
However, the real test will be how this subcommittee navigates the regulatory challenges, particularly with financial regulators and existing government frameworks. 
The clashes between those in favor of these new assets, and traditional institutions that have been historically resistant, are coming to a head.
The cryptocurrency industry is bracing for the results of this political initiative. 
These are crucial moments, as policy crafted within the confines of this Senate subcommittee will significantly impact the trajectory of digital asset development and integration into the American economy. 
This is no longer a niche industry, but a sector demanding <a href="https://www.benzinga.com/24/12/42356067/venture-capitalist-david-sacks-appointed-as-white-house-ai-crypto-czar-by-trump">a seat at the table</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42903474/xrp-etf-very-soon-likely-next-after-bitcoin-and-ethereum-ripple-president-says">XRP ETF &#8216;Very Soon,&#8217; Likely Next After Bitcoin And Ethereum, Ripple President Says</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Crypto's Capitol Hill Breakthrough: Senate Subcommittee Signals Shifting Political Winds

Avricore Health (TSE:AVCR) has released an update. Avricore Health Inc. reports a striking leap in financial performance for 2023, nearly doubling ...

Avricore Health Soars with Revenue and Partnerships

Avricore Health (TSE:AVCR) has released an update. Avricore Health Inc. has reported its first profitable quarter in early 2024, with a significant...

Avricore Health Celebrates First Profitable Quarter

Avricore Health (TSE:AVCR) has released an update. Avricore Health Inc. reports increased assets to $2.8 million and a net profit of $168,537 for t...

Avricore Health Posts Q1 Profit and Asset Growth

Avricore Health (TSE:AVCR) has released an update. Avricore Health Inc. has reported its first net profitability with a comprehensive income of $16...

Avricore Health Achieves First Net Profitability

Avricore Health reports 1H results

Avricore Health (TSE:AVCR) has released an update. Avricore Health Inc. has reported significant mid-year financial growth for 2024, with a 84% inc...

Avricore Health Boasts Robust Mid-Year Financials

Avricore Health (TSE:AVCR) has released an update. Avricore Health Inc. has announced the approval of stock options for directors, officers, employ...

Avricore Health Grants Stock Options and Touts HealthTab™

Avricore Health (TSE:AVCR) has released an update. Avricore Health has announced a strategic pivot to focus on the growing UK healthcare market, co...

Avricore Health Shifts Focus to UK Market

Avricore Health (TSE:AVCR) has released an update. Avricore Health Inc. reported a significant rise in revenues and profitability for the third qua...

Avricore Health Reports Revenue Surge and UK Expansion

Avricore Health (TSE:AVCR) has released an update. Avricore Health Inc. has been recognized in Deloitte Canada's 2024 Technology Fast 50 Companies-...

Comments

Avricore Health

空売り

Avricore Health (OTC:AVCRF) 株価情報, 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル